Free Consultation (800) 424-6690 Free Consultation (800) 424-6690 | [email protected]

Newsroom Search

featured news

February 28, 2014 Healthcare Fraud

Pharmaceutical Sales Whistleblower Sheds Light on Off-Label Marketing Scheme

It is unlawful for a pharmaceutical company to market a drug for purposes beyond those that have been approved by the Food and Drug Administration. When a company decides to sell a new drug to American consumers, the FDA ensures the drug is rigorously tested to reveal any deadly or […]
February 27, 2014 Healthcare Fraud

Department of Justice Combats Growing Trend of Fraud in the Dialysis Industry

In yesterday’s post, we discussed the recent onslaught of fraud in the kidney dialysis industry. In a recent $389 million settlement involving dialysis clinic company DaVita Healthcare Partners, the federal government put a stop to a lucrative but illegal kickback scheme involving equity-for-referral agreements between the defendant and several kidney […]
February 26, 2014 Healthcare Fraud

Settlement With DaVita Healthcare Partners Shows Fraud Trend in Dialysis Industry

Over the next two posts, we will explore an increasing fraud trend affecting the dialysis industry. As more and more Americans become dialysis-dependent, the opportunity to take advantage of government programs like Medicare and Medicaid grows – thereby creating an epidemic of niche fraud resulting in hundreds of millions of […]
February 24, 2014 Healthcare Fraud

Government Settles With Kentucky-Based Addiction Center Under False Claims Act

One of the hallmark goals of the False Claims Act is to help eliminate fraud and wasteful healthcare spending, thereby reducing healthcare costs for all Americans. In a recent settlement under the False Claims Act, a Kentucky-area addiction center and two of its physicians were found to be engaging in […]
February 20, 2014 Healthcare Fraud

Teva Pharmaceuticals Reveals Potential False Claims Act Liability in FY 2013 Report

Teva Pharmaceuticals, an Israeli-based drug maker, is at the mercy of the U.S. Department of Justice after allegations of False Claims Act violations surfaced late last year. The company is highly-respected for its Multiple Sclerosis and Parkinson’s Disease drugs, but has unfortunately been met with a subpoena for records pertaining […]
schedule a free consultation

"*" indicates required fields

By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.

in Settlements & Verdicts
Years of High-Profile Cases
Attorneys Protecting Your Rights
Named “Trial Lawyer of the Year”
States in Which The Firm Has Successfully Litigated Cases

On the Cutting Edge of the Profession

Legal Intelligencer